Latest news
25 items- SECSEC Form NT 10-Q filed by Priveterra Acquisition Corp. IINT 10-Q - Priveterra Acquisition Corp. II (0001821606) (Filer)
- PRPriveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KPriveterra Acquisition Corp. II (NASDAQ:PMGMU, PMGM, PMGMW))) (the "Company") today announced that on April 29, 2024, the Company received a notice (the "10-K Notice") from the staff of the Nasdaq Listing Qualifications department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") stating that, because the Company had not yet filed its Annual Report on Form 10-K for the period ended December 31, 2023 (the "Form 10-K"), the Company is not in compliance with Nasdaq Listing Rules for continued listing and, accordingly, such delinquency may serve as a separate basis for the delisting of the Company's securities from Nasdaq. The 10-K Notice also states that the Nasdaq Hearings Panel (the "P
- NEWSOn April 29, Priveterra Acquisition Corp II Got Additional Notice From Nasdaq, Co Is No Longer In Compliance With Nasdaq Listing Rule 5250(c)(1)- SEC Filing
- SECPriveterra Acquisition Corp. II filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Priveterra Acquisition Corp. II (0001821606) (Filer)
- SECSEC Form NT 10-K filed by Priveterra Acquisition Corp. IINT 10-K - Priveterra Acquisition Corp. II (0001821606) (Filer)
- SECPriveterra Acquisition Corp. II filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review8-K - AEON Biopharma, Inc. (0001837607) (Filer)
- 13D/GSEC Form SC 13G filed by Priveterra Acquisition Corp. IISC 13G - AEON Biopharma, Inc. (0001837607) (Subject)
- 13D/GSEC Form SC 13G/A filed by Priveterra Acquisition Corp. II (Amendment)SC 13G/A - AEON Biopharma, Inc. (0001837607) (Subject)
- SECSEC Form S-1/A filed by Priveterra Acquisition Corp. II (Amendment)S-1/A - AEON Biopharma, Inc. (0001837607) (Filer)
- SECSEC Form 10-Q filed by Priveterra Acquisition Corp. II10-Q - AEON Biopharma, Inc. (0001837607) (Filer)
- SECPriveterra Acquisition Corp. II filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - AEON Biopharma, Inc. (0001837607) (Filer)
- SECSEC Form S-1/A filed by Priveterra Acquisition Corp. II (Amendment)S-1/A - AEON Biopharma, Inc. (0001837607) (Filer)
- SECPriveterra Acquisition Corp. II filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - AEON Biopharma, Inc. (0001837607) (Filer)
- SECPriveterra Acquisition Corp. II filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - AEON Biopharma, Inc. (0001837607) (Filer)
- 13D/GSEC Form SC 13D/A filed by Priveterra Acquisition Corp. (Amendment)SC 13D/A - AEON Biopharma, Inc. (0001837607) (Subject)
- SECSEC Form DEL AM filed by Priveterra Acquisition Corp.DEL AM - AEON Biopharma, Inc. (0001837607) (Filer)
- SECSEC Form S-1 filed by Priveterra Acquisition Corp.S-1 - AEON Biopharma, Inc. (0001837607) (Filer)
- INSIDERSEC Form 4 filed by Thunen Shelley B4 - AEON Biopharma, Inc. (0001837607) (Issuer)
- INSIDERSEC Form 4 filed by Palmisano Robert J4 - AEON Biopharma, Inc. (0001837607) (Issuer)
- INSIDERSEC Form 4 filed by Fischer Jost4 - AEON Biopharma, Inc. (0001837607) (Issuer)
- INSIDERSEC Form 4 filed by Carter Eric G4 - AEON Biopharma, Inc. (0001837607) (Issuer)
- INSIDERSEC Form 4: Strathspey Crown Holdings Group, Llc sold $73,803,940 worth of shares (7,380,394 units at $10.00), decreasing direct ownership by 78% to 2,031,773 units4 - AEON Biopharma, Inc. (0001837607) (Issuer)
- SECPriveterra Acquisition Corp. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)8-K/A - AEON Biopharma, Inc. (0001837607) (Filer)
- INSIDERSEC Form 3: New insider Strathspey Crown Holdings Group, Llc claimed ownership of 9,420,370 shares3 - AEON Biopharma, Inc. (0001837607) (Issuer)
- 13D/GSEC Form SC 13D filed by Priveterra Acquisition Corp.SC 13D - AEON Biopharma, Inc. (0001837607) (Subject)
PMGM FAQ
6 questionsWhat does Priveterra Acquisition Corp. II do?
Priveterra Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with other businesses. The company was incorporated in 2020 and is based in Fort Lauderdale, Florida.Where does PMGM stock trade?
Priveterra Acquisition Corp. II (PMGM) is listed on NASDAQ.What sector and industry is PMGM in?
Priveterra Acquisition Corp. II operates in the Finance sector, Blank Checks industry.When did Priveterra Acquisition Corp. II go public?
Priveterra Acquisition Corp. II (PMGM) completed its IPO in 2021.What companies are similar to PMGM?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare PMGM side-by-side with any of them on Quantisnow.How can I track PMGM on Quantisnow?
Quantisnow aggregates Priveterra Acquisition Corp. II's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PMGM to receive live email and push alerts on every new disclosure.